Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic ductal adenocarcinoma treated with chemoradiotherapy - comparison of T category between the American Joint Committee on Cancer and Japan Pancreas Society.

Aoi Hayasaki,Shugo Mizuno,Motonori Nagata, Benson Kaluba,Koki Maeda,Toru Shinkai,Takahiro Ito,Kazuyuki Gyoten,Takehiro Fujii,Yusuke Iizawa,Akihiro Tanemura,Yasuhiro Murata,Naohisa Kuriyama,Shuji Isaji,Masashi Kishiwada

HPB : the official journal of the International Hepato Pancreato Biliary Association（2023）

引用 0|浏览7

暂无评分

摘要

In localized PDAC patients treated with chemoradiotherapy, extrapancreatic extension, as while as biological, conditional and therapeutic factors, is a better prognostic factor than tumor size.

查看译文

关键词

extrapancreatic ductal adenocarcinoma,extrapancreatic extension,tumor size,chemoradiotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要